

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | microglial cell activation (GO:0001774) | 6.51621361 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.21889932 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.21889932 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 6.21889932 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.21889932 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 6.21889932 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.21889932 |
| 8 | negative regulation of granulocyte differentiation (GO:0030853) | 6.00298238 |
| 9 | positive regulation of chemokine secretion (GO:0090197) | 5.94927167 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.83596479 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.65993267 |
| 12 | mannose metabolic process (GO:0006013) | 5.41357774 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83691504 |
| 14 | apoptotic cell clearance (GO:0043277) | 4.64002475 |
| 15 | complement activation, alternative pathway (GO:0006957) | 4.44635965 |
| 16 | macrophage activation (GO:0042116) | 4.44612298 |
| 17 | regulation of chemokine secretion (GO:0090196) | 4.36057575 |
| 18 | regulation of apoptotic cell clearance (GO:2000425) | 4.27140722 |
| 19 | keratan sulfate catabolic process (GO:0042340) | 4.25907071 |
| 20 | amino sugar catabolic process (GO:0046348) | 4.20826813 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.20241810 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.14788777 |
| 23 | regulation of macrophage chemotaxis (GO:0010758) | 4.12513685 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 4.11698221 |
| 25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.00653994 |
| 26 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.98471429 |
| 27 | adhesion of symbiont to host cell (GO:0044650) | 3.94546111 |
| 28 | virion attachment to host cell (GO:0019062) | 3.94546111 |
| 29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.89569940 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.87004468 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87004468 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 3.86402860 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.86222848 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.84215409 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78035850 |
| 36 | response to host immune response (GO:0052572) | 3.78035850 |
| 37 | myeloid dendritic cell differentiation (GO:0043011) | 3.68773932 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68654001 |
| 39 | response to host (GO:0075136) | 3.68654001 |
| 40 | response to host defenses (GO:0052200) | 3.68654001 |
| 41 | cellular extravasation (GO:0045123) | 3.61165540 |
| 42 | N-acetylneuraminate metabolic process (GO:0006054) | 3.59747951 |
| 43 | hyaluronan catabolic process (GO:0030214) | 3.56614363 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.53583685 |
| 45 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.49825635 |
| 46 | adhesion of symbiont to host (GO:0044406) | 3.48467533 |
| 47 | germinal center formation (GO:0002467) | 3.45366724 |
| 48 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.44742152 |
| 49 | barbed-end actin filament capping (GO:0051016) | 3.43710559 |
| 50 | membrane lipid catabolic process (GO:0046466) | 3.43064153 |
| 51 | monocyte chemotaxis (GO:0002548) | 3.41935936 |
| 52 | eosinophil chemotaxis (GO:0048245) | 3.41569743 |
| 53 | negative regulation of interleukin-6 production (GO:0032715) | 3.41508516 |
| 54 | regulation of integrin activation (GO:0033623) | 3.39880372 |
| 55 | sphingolipid catabolic process (GO:0030149) | 3.37622502 |
| 56 | I-kappaB phosphorylation (GO:0007252) | 3.37509825 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.37484751 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35920140 |
| 59 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.35647202 |
| 60 | lipoxygenase pathway (GO:0019372) | 3.33403097 |
| 61 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.33358830 |
| 62 | response to thyroid hormone (GO:0097066) | 3.33173353 |
| 63 | response to peptidoglycan (GO:0032494) | 3.32485568 |
| 64 | myeloid dendritic cell activation (GO:0001773) | 3.28506977 |
| 65 | negative regulation of macrophage differentiation (GO:0045650) | 3.28463424 |
| 66 | glycosphingolipid catabolic process (GO:0046479) | 3.27794539 |
| 67 | * complement activation (GO:0006956) | 3.26082048 |
| 68 | regulation of antigen processing and presentation (GO:0002577) | 3.23427991 |
| 69 | detection of molecule of bacterial origin (GO:0032490) | 3.23142246 |
| 70 | respiratory burst (GO:0045730) | 3.18284666 |
| 71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17225793 |
| 72 | regulation of podosome assembly (GO:0071801) | 3.16297327 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15219466 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14664148 |
| 75 | neutrophil activation involved in immune response (GO:0002283) | 3.12646556 |
| 76 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.12539280 |
| 77 | regulation of mononuclear cell migration (GO:0071675) | 3.10614518 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.08118660 |
| 79 | adenosine receptor signaling pathway (GO:0001973) | 3.07857311 |
| 80 | eosinophil migration (GO:0072677) | 3.07686975 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 3.07460471 |
| 82 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.06895507 |
| 83 | positive regulation of mast cell degranulation (GO:0043306) | 3.06895507 |
| 84 | positive regulation of heat generation (GO:0031652) | 3.04231927 |
| 85 | B cell mediated immunity (GO:0019724) | 3.03533775 |
| 86 | dendritic cell differentiation (GO:0097028) | 3.02213191 |
| 87 | positive regulation of leukocyte degranulation (GO:0043302) | 3.01990937 |
| 88 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.01593326 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00667887 |
| 90 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.99639797 |
| 91 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.96258174 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 2.95895554 |
| 93 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.95014463 |
| 94 | granulocyte activation (GO:0036230) | 2.94579074 |
| 95 | regulation of complement activation (GO:0030449) | 2.92624247 |
| 96 | regulation of cholesterol storage (GO:0010885) | 2.92424375 |
| 97 | regulation of phagocytosis (GO:0050764) | 2.92063502 |
| 98 | regulation of chemokine biosynthetic process (GO:0045073) | 2.91870951 |
| 99 | angiotensin maturation (GO:0002003) | 2.91352843 |
| 100 | glycolipid catabolic process (GO:0019377) | 2.91343434 |
| 101 | oligosaccharide catabolic process (GO:0009313) | 2.90619504 |
| 102 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.89270025 |
| 103 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.87433273 |
| 104 | regulation of vitamin metabolic process (GO:0030656) | 2.87241900 |
| 105 | endothelial cell chemotaxis (GO:0035767) | 2.85245990 |
| 106 | pinocytosis (GO:0006907) | 2.85051420 |
| 107 | response to muramyl dipeptide (GO:0032495) | 2.83939035 |
| 108 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82457785 |
| 109 | adaptation of signaling pathway (GO:0023058) | 2.82450734 |
| 110 | regulation of fever generation (GO:0031620) | 2.82114061 |
| 111 | cellular response to interferon-gamma (GO:0071346) | 2.82021230 |
| 112 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81042556 |
| 113 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80903273 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80852674 |
| 115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.80842512 |
| 116 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79185344 |
| 117 | * complement activation, classical pathway (GO:0006958) | 2.79130143 |
| 118 | positive regulation of phagocytosis (GO:0050766) | 2.78555190 |
| 119 | macrophage differentiation (GO:0030225) | 2.77842640 |
| 120 | response to protozoan (GO:0001562) | 2.77696841 |
| 121 | regulation of protein activation cascade (GO:2000257) | 2.77664790 |
| 122 | chondroitin sulfate catabolic process (GO:0030207) | 2.76557846 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.76385193 |
| 124 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.76103286 |
| 125 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.75667314 |
| 126 | detection of external biotic stimulus (GO:0098581) | 2.75381092 |
| 127 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.75187745 |
| 128 | defense response to protozoan (GO:0042832) | 2.74744046 |
| 129 | low-density lipoprotein particle clearance (GO:0034383) | 2.74469507 |
| 130 | negative regulation of bone resorption (GO:0045779) | 2.74188818 |
| 131 | regulation of leukocyte degranulation (GO:0043300) | 2.74122139 |
| 132 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.73857146 |
| 133 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.72198248 |
| 134 | positive regulation of cholesterol efflux (GO:0010875) | 2.70458719 |
| 135 | response to cholesterol (GO:0070723) | 2.68873582 |
| 136 | regulation of granulocyte differentiation (GO:0030852) | 2.68683094 |
| 137 | cellular response to lipopolysaccharide (GO:0071222) | 2.68424671 |
| 138 | detection of other organism (GO:0098543) | 2.68372594 |
| 139 | regulation of monocyte chemotaxis (GO:0090025) | 2.68199881 |
| 140 | response to interferon-gamma (GO:0034341) | 2.68031385 |
| 141 | type I interferon signaling pathway (GO:0060337) | 2.67530896 |
| 142 | cellular response to type I interferon (GO:0071357) | 2.67530896 |
| 143 | response to laminar fluid shear stress (GO:0034616) | 2.66320098 |
| 144 | protein carboxylation (GO:0018214) | 2.64407858 |
| 145 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.64407858 |
| 146 | positive regulation of Rap GTPase activity (GO:0032854) | 2.63482394 |
| 147 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62395476 |
| 148 | negative regulation of tissue remodeling (GO:0034104) | 2.62151380 |
| 149 | phagocytosis, engulfment (GO:0006911) | 2.61326004 |
| 150 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.59910641 |
| 151 | positive regulation of interferon-beta production (GO:0032728) | 2.59640282 |
| 152 | ruffle organization (GO:0031529) | 2.59524821 |
| 153 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58170287 |
| 154 | lymphocyte chemotaxis (GO:0048247) | 2.57359459 |
| 155 | purinergic receptor signaling pathway (GO:0035587) | 2.57176747 |
| 156 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55749714 |
| 157 | ceramide catabolic process (GO:0046514) | 2.55659962 |
| 158 | regulation of mast cell degranulation (GO:0043304) | 2.50713905 |
| 159 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.50221165 |
| 160 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49499096 |
| 161 | cyclooxygenase pathway (GO:0019371) | 2.47785852 |
| 162 | leukotriene metabolic process (GO:0006691) | 2.47479336 |
| 163 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.45659408 |
| 164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45659408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.17385693 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.94094766 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.20435277 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90144746 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.60724780 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.36040667 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13085199 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.86897226 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76893670 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.74828558 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.67433523 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46766540 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36746698 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32686425 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.28642029 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.26414253 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15931568 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10348800 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05697919 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03220469 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01856518 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01010530 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89976195 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.84431526 |
| 25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83783435 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77307119 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76740713 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73498538 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70812897 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69428821 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66675297 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65789627 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63105222 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61589809 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61430462 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.55912732 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54368855 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53208099 |
| 39 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.51296326 |
| 40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50894416 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48260537 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48192442 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.47665809 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47537629 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47111093 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46380778 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44356581 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43368504 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37663073 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37565659 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36280419 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35590885 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35256384 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34648244 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34340583 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31327929 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29242616 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.29207007 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28766201 |
| 60 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.25870132 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25043005 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24819230 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23417324 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21471770 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21023362 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21022355 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18622558 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18435086 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17278833 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17276881 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17232359 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16075290 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15038189 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14552524 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12623983 |
| 76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11175951 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11142875 |
| 78 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09109235 |
| 79 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09060229 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08356027 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08230892 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07563677 |
| 83 | MYC_22102868_ChIP-Seq_BL_Human | 1.07207210 |
| 84 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05684371 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05667717 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05639297 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04127385 |
| 88 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03771556 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02743401 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01148539 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00705200 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00704857 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00677819 |
| 94 | MYB_26560356_Chip-Seq_TH2_Human | 1.00321027 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00276834 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97909236 |
| 97 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97859394 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96468633 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96446713 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95720423 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95445279 |
| 102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95397499 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95150555 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94429100 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.92798234 |
| 106 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92386139 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91267989 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90871060 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88999032 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87959735 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87016410 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86545608 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85005036 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84772492 |
| 115 | MYB_26560356_Chip-Seq_TH1_Human | 0.84319250 |
| 116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84279096 |
| 117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84267680 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82829202 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82199073 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80785103 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80568023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.17494749 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.53554998 |
| 3 | MP0009840_abnormal_foam_cell | 3.95281529 |
| 4 | MP0006082_CNS_inflammation | 3.59004998 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.22647828 |
| 6 | MP0003303_peritoneal_inflammation | 3.11774849 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.96968490 |
| 8 | MP0003436_decreased_susceptibility_to | 2.89300305 |
| 9 | MP0002419_abnormal_innate_immunity | 2.63785984 |
| 10 | MP0003690_abnormal_glial_cell | 2.59616305 |
| 11 | MP0003075_altered_response_to | 2.59141672 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.33073618 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.31602051 |
| 14 | MP0001533_abnormal_skeleton_physiology | 2.20008255 |
| 15 | MP0003724_increased_susceptibility_to | 2.19598832 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.17183238 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.12855667 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.03079316 |
| 19 | MP0001790_abnormal_immune_system | 1.98666980 |
| 20 | MP0005387_immune_system_phenotype | 1.98666980 |
| 21 | * MP0005000_abnormal_immune_tolerance | 1.96906940 |
| 22 | MP0000343_altered_response_to | 1.94787799 |
| 23 | * MP0005025_abnormal_response_to | 1.90044167 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.89563854 |
| 25 | MP0005671_abnormal_response_to | 1.82809711 |
| 26 | MP0000604_amyloidosis | 1.82042114 |
| 27 | MP0004510_myositis | 1.76968931 |
| 28 | MP0000685_abnormal_immune_system | 1.75757115 |
| 29 | MP0001800_abnormal_humoral_immune | 1.75014452 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.70819793 |
| 31 | MP0002723_abnormal_immune_serum | 1.64715868 |
| 32 | MP0005670_abnormal_white_adipose | 1.56710480 |
| 33 | MP0008469_abnormal_protein_level | 1.56348002 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.55138834 |
| 35 | MP0005166_decreased_susceptibility_to | 1.54547080 |
| 36 | MP0006054_spinal_hemorrhage | 1.50714189 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.47980199 |
| 38 | MP0001819_abnormal_immune_cell | 1.47840341 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.47633325 |
| 40 | MP0008004_abnormal_stomach_pH | 1.46577292 |
| 41 | MP0003329_amyloid_beta_deposits | 1.46389307 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.45754583 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.45168086 |
| 44 | MP0009785_altered_susceptibility_to | 1.45070903 |
| 45 | MP0001851_eye_inflammation | 1.44416658 |
| 46 | MP0005451_abnormal_body_composition | 1.43767361 |
| 47 | MP0004947_skin_inflammation | 1.37459971 |
| 48 | * MP0001845_abnormal_inflammatory_respons | 1.36949492 |
| 49 | MP0000858_altered_metastatic_potential | 1.35822465 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.34451467 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.34075430 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.33947355 |
| 53 | MP0003252_abnormal_bile_duct | 1.31826598 |
| 54 | MP0002405_respiratory_system_inflammati | 1.28484909 |
| 55 | MP0009278_abnormal_bone_marrow | 1.26344931 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.23695652 |
| 57 | MP0000249_abnormal_blood_vessel | 1.23239552 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.19261080 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.17275220 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.16626434 |
| 61 | MP0004130_abnormal_muscle_cell | 1.16485781 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.13044197 |
| 63 | MP0001915_intracranial_hemorrhage | 1.11621794 |
| 64 | MP0002254_reproductive_system_inflammat | 1.11236481 |
| 65 | MP0000609_abnormal_liver_physiology | 1.10762757 |
| 66 | MP0003045_fibrosis | 1.10101739 |
| 67 | MP0002090_abnormal_vision | 1.09092067 |
| 68 | MP0003279_aneurysm | 1.09072427 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.08317451 |
| 70 | MP0001853_heart_inflammation | 1.07466877 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.07284081 |
| 72 | MP0005023_abnormal_wound_healing | 1.05151767 |
| 73 | MP0005310_abnormal_salivary_gland | 1.03329638 |
| 74 | MP0000716_abnormal_immune_system | 1.02842266 |
| 75 | MP0001542_abnormal_bone_strength | 1.01964625 |
| 76 | MP0005390_skeleton_phenotype | 1.01692134 |
| 77 | MP0004883_abnormal_blood_vessel | 1.01392747 |
| 78 | MP0009763_increased_sensitivity_to | 1.00896171 |
| 79 | MP0003195_calcinosis | 0.97002806 |
| 80 | MP0008260_abnormal_autophagy | 0.96791330 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.96663492 |
| 82 | MP0003448_altered_tumor_morphology | 0.95525389 |
| 83 | MP0005165_increased_susceptibility_to | 0.95262672 |
| 84 | MP0001663_abnormal_digestive_system | 0.94185766 |
| 85 | MP0002139_abnormal_hepatobiliary_system | 0.92490075 |
| 86 | MP0005360_urolithiasis | 0.89859326 |
| 87 | MP0005365_abnormal_bile_salt | 0.87964437 |
| 88 | MP0002928_abnormal_bile_duct | 0.87955832 |
| 89 | MP0003634_abnormal_glial_cell | 0.85901202 |
| 90 | MP0002933_joint_inflammation | 0.84605233 |
| 91 | MP0008873_increased_physiological_sensi | 0.83897984 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.83708589 |
| 93 | MP0010155_abnormal_intestine_physiology | 0.82198566 |
| 94 | MP0009764_decreased_sensitivity_to | 0.80917905 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.80170131 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79931779 |
| 97 | MP0002429_abnormal_blood_cell | 0.79713664 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.79640809 |
| 99 | MP0003795_abnormal_bone_structure | 0.78690238 |
| 100 | MP0002722_abnormal_immune_system | 0.78631339 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.77814626 |
| 102 | MP0002398_abnormal_bone_marrow | 0.77740534 |
| 103 | MP0003828_pulmonary_edema | 0.76565431 |
| 104 | MP0000920_abnormal_myelination | 0.76329050 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.76036223 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.76036223 |
| 107 | MP0010307_abnormal_tumor_latency | 0.75167580 |
| 108 | MP0005164_abnormal_response_to | 0.74982598 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.72982460 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.72723988 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.72549825 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.72521117 |
| 113 | MP0003633_abnormal_nervous_system | 0.72060524 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.71400386 |
| 115 | MP0000598_abnormal_liver_morphology | 0.70717253 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.70677122 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.70431393 |
| 118 | MP0005647_abnormal_sex_gland | 0.70384377 |
| 119 | MP0001873_stomach_inflammation | 0.68797789 |
| 120 | MP0003091_abnormal_cell_migration | 0.68021438 |
| 121 | MP0003879_abnormal_hair_cell | 0.67325814 |
| 122 | MP0002006_tumorigenesis | 0.66405861 |
| 123 | MP0008874_decreased_physiological_sensi | 0.65213183 |
| 124 | MP0003186_abnormal_redox_activity | 0.64651289 |
| 125 | MP0004858_abnormal_nervous_system | 0.63904169 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.63573023 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.61595040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Glomerulonephritis (HP:0000099) | 7.39574483 |
| 2 | * Complement deficiency (HP:0004431) | 6.52243676 |
| 3 | * Abnormality of complement system (HP:0005339) | 5.73827583 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.69101975 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.69101975 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.69101975 |
| 7 | Dysostosis multiplex (HP:0000943) | 5.66278269 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 5.22739156 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.72371691 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.72265773 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.56159340 |
| 12 | Mucopolysacchariduria (HP:0008155) | 4.43289883 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.43289883 |
| 14 | Cerebral aneurysm (HP:0004944) | 4.31343778 |
| 15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.15769012 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.15769012 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.15769012 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 4.15277777 |
| 19 | * Nephritis (HP:0000123) | 4.01355755 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96736823 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.89976275 |
| 22 | Arterial tortuosity (HP:0005116) | 3.89930452 |
| 23 | Nuclear cataract (HP:0100018) | 3.77011286 |
| 24 | Mutism (HP:0002300) | 3.72266737 |
| 25 | Axonal loss (HP:0003447) | 3.60724439 |
| 26 | Retinal atrophy (HP:0001105) | 3.49544351 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.48072219 |
| 28 | Vascular tortuosity (HP:0004948) | 3.40830745 |
| 29 | Disinhibition (HP:0000734) | 3.37665896 |
| 30 | Hematochezia (HP:0002573) | 3.17130856 |
| 31 | Loss of speech (HP:0002371) | 3.07778968 |
| 32 | Purpura (HP:0000979) | 3.05324641 |
| 33 | Spondylolisthesis (HP:0003302) | 2.83380866 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.81340109 |
| 35 | Orchitis (HP:0100796) | 2.77298816 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.77022752 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.75954534 |
| 38 | Increased serum ferritin (HP:0003281) | 2.65924976 |
| 39 | Personality changes (HP:0000751) | 2.65924912 |
| 40 | Aortic aneurysm (HP:0004942) | 2.64840838 |
| 41 | Upper motor neuron abnormality (HP:0002127) | 2.62796447 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.61007106 |
| 43 | Progressive neurologic deterioration (HP:0002344) | 2.60284091 |
| 44 | Malnutrition (HP:0004395) | 2.56626729 |
| 45 | Myocardial infarction (HP:0001658) | 2.54579452 |
| 46 | Striae distensae (HP:0001065) | 2.53946098 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.53258285 |
| 48 | Thoracic kyphosis (HP:0002942) | 2.51365031 |
| 49 | Stomatitis (HP:0010280) | 2.50434053 |
| 50 | Pathologic fracture (HP:0002756) | 2.50404409 |
| 51 | Joint stiffness (HP:0001387) | 2.49230311 |
| 52 | Colitis (HP:0002583) | 2.47965867 |
| 53 | Amyloidosis (HP:0011034) | 2.47567553 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.46569926 |
| 55 | Optic neuritis (HP:0100653) | 2.46569926 |
| 56 | Disproportionate tall stature (HP:0001519) | 2.45809224 |
| 57 | Agnosia (HP:0010524) | 2.38643516 |
| 58 | Aortic dissection (HP:0002647) | 2.38546913 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.35055709 |
| 60 | Metaphyseal irregularity (HP:0003025) | 2.34746959 |
| 61 | Recurrent skin infections (HP:0001581) | 2.32513077 |
| 62 | Abnormality of the lumbar spine (HP:0100712) | 2.31741081 |
| 63 | Pustule (HP:0200039) | 2.28726505 |
| 64 | Prolonged neonatal jaundice (HP:0006579) | 2.27596244 |
| 65 | Hepatosplenomegaly (HP:0001433) | 2.27317403 |
| 66 | Conjunctival telangiectasia (HP:0000524) | 2.23174729 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22786004 |
| 68 | Petechiae (HP:0000967) | 2.22505866 |
| 69 | Polygenic inheritance (HP:0010982) | 2.21362196 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.19194205 |
| 71 | Cardiomegaly (HP:0001640) | 2.17843649 |
| 72 | Gingivitis (HP:0000230) | 2.17550037 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.15957374 |
| 74 | Deep venous thrombosis (HP:0002625) | 2.15390775 |
| 75 | Ovoid vertebral bodies (HP:0003300) | 2.13298054 |
| 76 | Apathy (HP:0000741) | 2.07498698 |
| 77 | Joint hemorrhage (HP:0005261) | 2.03981663 |
| 78 | Bone pain (HP:0002653) | 2.03567256 |
| 79 | Supranuclear gaze palsy (HP:0000605) | 2.01861728 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.01615213 |
| 81 | Hemoptysis (HP:0002105) | 2.00294261 |
| 82 | * Systemic lupus erythematosus (HP:0002725) | 10.0015186 |
| 83 | Urethral obstruction (HP:0000796) | 1.99825061 |
| 84 | Diminished motivation (HP:0000745) | 1.99211759 |
| 85 | Vertebral compression fractures (HP:0002953) | 1.98147935 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95173428 |
| 87 | Memory impairment (HP:0002354) | 1.95138497 |
| 88 | Inflammation of the large intestine (HP:0002037) | 1.92414871 |
| 89 | Shallow orbits (HP:0000586) | 1.91637980 |
| 90 | Peripheral demyelination (HP:0011096) | 1.91042044 |
| 91 | Mitral valve prolapse (HP:0001634) | 1.90333018 |
| 92 | Increased CSF protein (HP:0002922) | 1.89464814 |
| 93 | Polyneuropathy (HP:0001271) | 1.89444445 |
| 94 | Nausea (HP:0002018) | 1.87515068 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.86270215 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86270215 |
| 97 | Interstitial pulmonary disease (HP:0006530) | 1.86090114 |
| 98 | Progressive visual loss (HP:0000529) | 1.85730630 |
| 99 | Thick nail (HP:0001805) | 1.84773410 |
| 100 | Dementia (HP:0000726) | 1.83657984 |
| 101 | Deformed sella turcica (HP:0002681) | 1.83601893 |
| 102 | Xanthomatosis (HP:0000991) | 1.81888761 |
| 103 | Periodontitis (HP:0000704) | 1.81880953 |
| 104 | Myositis (HP:0100614) | 1.81564320 |
| 105 | Bone cyst (HP:0012062) | 1.81505097 |
| 106 | Vasculitis (HP:0002633) | 1.80498322 |
| 107 | Abnormality of the thoracic spine (HP:0100711) | 1.79357537 |
| 108 | Restrictive lung disease (HP:0002091) | 1.78874799 |
| 109 | Mediastinal lymphadenopathy (HP:0100721) | 1.78825229 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.78063625 |
| 111 | Basal ganglia calcification (HP:0002135) | 1.76250503 |
| 112 | Peritonitis (HP:0002586) | 1.75977511 |
| 113 | Meningitis (HP:0001287) | 1.73895814 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73869823 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 1.73236163 |
| 116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73094383 |
| 117 | Abnormality of the periventricular white matter (HP:0002518) | 1.73091023 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 1.73077694 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.72251508 |
| 120 | Cellulitis (HP:0100658) | 1.72193510 |
| 121 | Coarse hair (HP:0002208) | 1.71356442 |
| 122 | Obstructive lung disease (HP:0006536) | 1.71185556 |
| 123 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71185556 |
| 124 | Abnormality of the basal ganglia (HP:0002134) | 1.70764138 |
| 125 | Orthostatic hypotension (HP:0001278) | 1.70665782 |
| 126 | Cervical subluxation (HP:0003308) | 1.69792860 |
| 127 | Global brain atrophy (HP:0002283) | 1.69729299 |
| 128 | Mitral stenosis (HP:0001718) | 1.69550633 |
| 129 | Mucosal telangiectasiae (HP:0100579) | 1.68206399 |
| 130 | Keratoconjunctivitis sicca (HP:0001097) | 1.67825953 |
| 131 | Inappropriate behavior (HP:0000719) | 1.67428434 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.67363246 |
| 133 | Hand muscle atrophy (HP:0009130) | 1.67001485 |
| 134 | Impaired platelet aggregation (HP:0003540) | 1.66482236 |
| 135 | Abnormal platelet function (HP:0011869) | 1.66482236 |
| 136 | Acrocyanosis (HP:0001063) | 1.66235135 |
| 137 | Urticaria (HP:0001025) | 1.62797614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 6.51233023 |
| 2 | NME2 | 4.51156745 |
| 3 | BLK | 3.71068035 |
| 4 | MAPK15 | 3.30556017 |
| 5 | ERN1 | 3.25071407 |
| 6 | CAMK1D | 3.08881199 |
| 7 | TYK2 | 3.08814595 |
| 8 | CSF1R | 2.99817362 |
| 9 | DDR2 | 2.69923714 |
| 10 | GRK7 | 2.61478722 |
| 11 | TAOK2 | 2.36957150 |
| 12 | CAMK1G | 2.31456980 |
| 13 | TRIB3 | 2.29787237 |
| 14 | MST1R | 2.25514195 |
| 15 | TBK1 | 2.15830504 |
| 16 | ACVR1B | 2.08365000 |
| 17 | RIPK4 | 2.05314344 |
| 18 | TAOK1 | 2.01883243 |
| 19 | PAK4 | 1.90235324 |
| 20 | PKN2 | 1.86721053 |
| 21 | EPHB1 | 1.83690574 |
| 22 | IRAK4 | 1.81211673 |
| 23 | PIM2 | 1.80419728 |
| 24 | MAP4K1 | 1.75650859 |
| 25 | JAK1 | 1.68796556 |
| 26 | ABL2 | 1.67805296 |
| 27 | RIPK1 | 1.58984074 |
| 28 | CAMKK2 | 1.56458425 |
| 29 | CDC42BPA | 1.50943291 |
| 30 | IRAK3 | 1.47929461 |
| 31 | PRPF4B | 1.45954663 |
| 32 | CSK | 1.41426776 |
| 33 | ZAP70 | 1.40228880 |
| 34 | MAP2K3 | 1.35794892 |
| 35 | FES | 1.34821794 |
| 36 | KIT | 1.34102480 |
| 37 | TESK1 | 1.33669405 |
| 38 | PTK6 | 1.32657930 |
| 39 | HCK | 1.31802234 |
| 40 | CAMKK1 | 1.30149242 |
| 41 | TSSK6 | 1.30025521 |
| 42 | MATK | 1.19440389 |
| 43 | STK10 | 1.16868681 |
| 44 | MAP3K14 | 1.15998774 |
| 45 | JAK2 | 1.14669888 |
| 46 | TESK2 | 1.07027719 |
| 47 | EPHB2 | 1.05718355 |
| 48 | SCYL2 | 1.01006300 |
| 49 | NEK9 | 0.96556640 |
| 50 | CLK1 | 0.93072682 |
| 51 | MAPK12 | 0.92091325 |
| 52 | FGR | 0.91525759 |
| 53 | CHUK | 0.90884577 |
| 54 | TGFBR1 | 0.90444069 |
| 55 | TTN | 0.89657645 |
| 56 | TAOK3 | 0.86174198 |
| 57 | IKBKB | 0.85795064 |
| 58 | IKBKE | 0.81554595 |
| 59 | LCK | 0.81222919 |
| 60 | MOS | 0.80986346 |
| 61 | MAP3K13 | 0.80383394 |
| 62 | DAPK2 | 0.77646775 |
| 63 | LYN | 0.76945229 |
| 64 | MAP2K6 | 0.75183645 |
| 65 | SYK | 0.72968392 |
| 66 | MAP3K5 | 0.72642325 |
| 67 | BMX | 0.71629259 |
| 68 | MAP3K3 | 0.69934840 |
| 69 | IGF1R | 0.67998449 |
| 70 | BMPR2 | 0.67165708 |
| 71 | FGFR4 | 0.66143019 |
| 72 | PIK3CG | 0.65629602 |
| 73 | MET | 0.65245599 |
| 74 | BTK | 0.63858601 |
| 75 | PDPK1 | 0.62520053 |
| 76 | PAK2 | 0.62254776 |
| 77 | SIK3 | 0.61035037 |
| 78 | PDK1 | 0.60501502 |
| 79 | PDGFRA | 0.59749964 |
| 80 | CDK6 | 0.59379243 |
| 81 | PRKG2 | 0.57760078 |
| 82 | TYRO3 | 0.57391628 |
| 83 | IRAK2 | 0.56775575 |
| 84 | ITK | 0.56669090 |
| 85 | TNK2 | 0.56462797 |
| 86 | ARAF | 0.55868127 |
| 87 | EEF2K | 0.55863377 |
| 88 | CAMK4 | 0.55672333 |
| 89 | EGFR | 0.54726620 |
| 90 | MAPKAPK3 | 0.52406056 |
| 91 | SIK2 | 0.51728764 |
| 92 | GSK3A | 0.49109708 |
| 93 | IRAK1 | 0.48685483 |
| 94 | MAPKAPK2 | 0.48440999 |
| 95 | MAP3K9 | 0.48096350 |
| 96 | GRK5 | 0.47695436 |
| 97 | PRKCH | 0.47051190 |
| 98 | ICK | 0.46424318 |
| 99 | MAP3K11 | 0.46286183 |
| 100 | JAK3 | 0.45338887 |
| 101 | MAP3K10 | 0.44381023 |
| 102 | LRRK2 | 0.43403673 |
| 103 | RPS6KA2 | 0.43271377 |
| 104 | LIMK1 | 0.42687744 |
| 105 | RET | 0.42658489 |
| 106 | TXK | 0.42329769 |
| 107 | MARK3 | 0.42325984 |
| 108 | EPHA3 | 0.41465745 |
| 109 | DAPK3 | 0.40687105 |
| 110 | RPS6KA4 | 0.40366244 |
| 111 | SIK1 | 0.38905733 |
| 112 | ABL1 | 0.38283973 |
| 113 | ADRBK2 | 0.38117495 |
| 114 | PIM1 | 0.38049216 |
| 115 | FGFR3 | 0.37698815 |
| 116 | MAPK7 | 0.37335342 |
| 117 | MAP3K1 | 0.36467184 |
| 118 | KSR2 | 0.35888118 |
| 119 | FYN | 0.35360704 |
| 120 | PTK2B | 0.34987236 |
| 121 | PRKD1 | 0.34666858 |
| 122 | PRKCD | 0.34112612 |
| 123 | PRKAA2 | 0.33710304 |
| 124 | GRK6 | 0.32372786 |
| 125 | PDK2 | 0.31583734 |
| 126 | INSR | 0.31501368 |
| 127 | RPS6KA6 | 0.31104164 |
| 128 | MARK2 | 0.30611732 |
| 129 | MAP3K6 | 0.28584099 |
| 130 | RPS6KL1 | 0.28395340 |
| 131 | RPS6KC1 | 0.28395340 |
| 132 | MAPK4 | 0.28250760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.03110296 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.89909814 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.79445224 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.27318968 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.02727533 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.80673321 |
| 7 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80574736 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.70270826 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.47022733 |
| 10 | * Pertussis_Homo sapiens_hsa05133 | 2.32537636 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.30494829 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29204787 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26766107 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18374426 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09692123 |
| 16 | * Prion diseases_Homo sapiens_hsa05020 | 1.91202010 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81123983 |
| 18 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64244837 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56950125 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.52638029 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51993817 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49374365 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.41762606 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35843141 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.28957454 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.26735450 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24367611 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23300499 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22414895 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07455835 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04241729 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 0.94810051 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 0.93115069 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92605431 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87040249 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83600050 |
| 37 | Endocytosis_Homo sapiens_hsa04144 | 0.82645509 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 0.81039081 |
| 39 | Measles_Homo sapiens_hsa05162 | 0.80904161 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80638327 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 0.80095624 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79916362 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79507290 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.78820334 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78801182 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78422576 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78100007 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75973026 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 0.75756939 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75501912 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75195933 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73899814 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72723831 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71873321 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70976219 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69702759 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68142074 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67930330 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65395098 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64742241 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64486565 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64279125 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62973846 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60605232 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57430654 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.57199040 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.55978075 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51578358 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51204582 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51176433 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50248081 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49951935 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49268216 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49025199 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46403913 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46239751 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.44402044 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44249976 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44197565 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43111446 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.42677327 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42600281 |
| 83 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41694792 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41660311 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40218948 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40174139 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38824722 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38817545 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37073636 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36965142 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36844196 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.35242790 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.33922539 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33368099 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33279550 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.33064401 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32819057 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32501649 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31423587 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31039808 |
| 101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30954822 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.30323111 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30063184 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29543060 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29440666 |
| 106 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26984386 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26487990 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25212960 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24110638 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24068806 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22645858 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22411609 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22181387 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21783014 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21121908 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.20313909 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19701313 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.19196709 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18491213 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18043626 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17640535 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17562655 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.17505533 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17471521 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14589747 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14342667 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.13112159 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10580110 |

